RESOURCES CLINICAL TRIALS PUBLICATIONS  
     
CURRENT TRIALS
A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 (Champion2)
Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders (CTS-1027-04)
Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders
A Phase 3, Double-Blind, Placebo-Controlled Trial and Long Term Safety Extension of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
PREVIOUSLY MANAGED TRIALS
CTS-1027 in Interferon-Naive Hepatitis C Patients
Study of CTS-1027 in Hepatitis C Patients
AST-120 Used to Treat Mild Hepatic Encephalopathy (ASTUTE)
Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (AST015)
A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection
Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patient With Hepatic Insufficiency
Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (SILVER)
 









 

Copyright © 2011  SCLRC - SC Liver Research Consortium LLC  All rights reserved
11025 North Torrey Pines Road, Suite 200, La Jolla  CA  92037
1-877-415-9504


site created by THE CODE CREW